Skip to content
The Nexus
DossierENTITY

Cancer Medicines

Coverage of Cancer Medicines in the Nexus archive.

Earliest in view: Apr 29 · 06:12 UTCMost recent: Aug 14 · 07:30 UTC
Co-mentioned in this coverage
National Association of Boards of Pharmacyorganization1Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Acttopic1U.S. Food and Drug Administrationorganization1Louisianaplace1pharmaceutical supply chaintopic1health ministryorganization1QR code-based drug traceabilitytopic1vaccinestopic1antimicrobialstopic1NDPS medicinestopic1Drugs Rulestopic1Schedule H2topic1GlaxoSmithKlineorganization1HIVtopic1Londonplace1Jason Aldenperson1Bloombergorganization1
Recent coverage
  • HEALTHAug 14 · 07:30 UTCOHIO CAPITAL JOURNAL
    Cancer patients deserve peace of mind when it comes to medication

    Cancer medicine treatments face pharmaceutical supply chain challenges, including drug shortages and reports of counterfeit medicines reaching U.S. clinics. Efforts to strengthen safety involve legislative solutions like the proposed Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act and regulatory improvements by organizations such as NABP. Furthermore, patient education is stressed as essential so that individuals understand if a medication is FDA-approved or compounded for an individual need.

  • HEALTHJun 25 · 13:17 UTCTHE HINDU NATIONAL
    Health Ministry expands QR code-based drug traceability to vaccines, antimicrobials, and cancer medicines

    The Health Ministry has expanded QR code-based drug traceability to include vaccines, antimicrobials, cancer medicines, and NDPS medicines under amended Drugs Rules. Implementation will be phased, starting from July 2027.

  • BUSINESSApr 29 · 06:12 UTCBLOOMBERG
    GSK Profit Beats Estimates on HIV, Cancer Medicines

    GlaxoSmithKline (GSK) reported higher-than-expected profits driven by sales of its HIV and cancer medications. The company's London-based headquarters was highlighted in the article.